Delhi High Court Permits JNTL to Sell ₹180-Crore ORSL Stock Despite FSSAI Dispute

delhi high court ors

Credits: Canva

Text

Updated Oct 19, 2025 | 12:06 PM IST

SummaryThe Delhi High Court has granted interim protection to JNTL Consumer Health, allowing the company to sell its existing ₹180 crore stock of ORSL despite FSSAI’s prohibition on using “ORS” in product names. Hyderabad paediatrician Dr. Sivaranjani Santosh, who has campaigned for years against misleading medical-sounding labels, has renewed her call for strict regulatory action, warning that such branding could endanger children’s health.

End of Article